GE HealthCare
GE HealthCare is a leading global innovator in medical technology and digital solutions, holding a significant position as a key player in the Ultrasound AI market. The company offers a comprehensive range of ultrasound systems, including portable, point-of-care (POCUS), and premium cart-based units. Its core strategy in this domain is the development and commercialization of AI and cloud-based solutions, which are essential for enhancing diagnostic accuracy and streamlining clinical workflows. Through its Verisound™ Digital & AI Ultrasound Solutions, GE HealthCare is focused on simplifying the complex ultrasound workflow, eliminating non-value-add tasks, and automating where possible across all major clinical segments: Radiology, OB/GYN, Cardiology, and POCUS. The company leverages advanced AI and Machine Learning (ML) algorithms to improve imaging accuracy, automate measurements, reduce diagnostic variability, and provide clinical support. Recent innovations include the launch of AI-enhanced Women’s Health ultrasound systems, which integrate advanced automation tools to support earlier and more accurate detection, cementing GE HealthCare’s role as a leader in transforming medical imaging through intelligence.
Latest Market Research Report on Ultrasound AI Download PDF Brochure Now
Koninklijke Philips N.V.
Koninklijke Philips N.V., a global leader in health technology, is a top-tier player in the Ultrasound AI market, primarily through its Connected Care segment and its established portfolio of ultrasound devices like the EPIQ and Affiniti series. Philips’ strategy involves the deep integration of AI across its ultrasound platforms to deliver enhanced image quality, automate complex measurements, and provide intelligent decision support tools, thereby augmenting user skills and reducing cognitive burden. The company’s AI-based solutions, such as 3D Auto Color Flow Quantification for assessing mitral regurgitation and SmartView Select for preselecting optimal apical cardiac views, are engineered to integrate seamlessly into everyday clinical workflows, ensuring more intuitive and reproducible ultrasound results. Philips is also focused on expanding the use of ultrasound through portable and point-of-care solutions. Furthermore, the company has strategically invested in AI-enabled capabilities, notably through the acquisition of SpectraWAVE Inc., specializing in AI-powered advanced vascular imaging, which further strengthens Philips’ position in image-guided coronary interventions and precision diagnostics.
Siemens Healthineers
Siemens Healthineers is a globally recognized medical technology company that is a prominent leader in the Ultrasound AI market. The company’s core focus is on combining the power of artificial intelligence with advanced imaging technologies to streamline clinical decision-making and enhance the efficiency of diagnostic workflows. Siemens Healthineers is committed to developing AI-enabled ultrasound systems that offer real-time analytics and workflow automation features. These solutions are designed to boost both the speed and precision of diagnostic procedures, thereby supporting clinicians in overcoming clinical challenges and elevating the standard of patient care. By providing sophisticated and reliable AI infrastructure within their ultrasound platforms, Siemens Healthineers reinforces its reputation as a key global provider, driving scientific advancements and contributing to the modernization and greater accessibility of precision diagnostics in the healthcare sector worldwide.
Clarius Mobile Health
Clarius Mobile Health is an innovative global leader specializing in AI-powered handheld ultrasound devices, effectively establishing its position at the forefront of the Point-of-Care Ultrasound (POCUS) space. The company’s success is driven by its focus on evidence-based clinical innovation and rigorous operational execution, which led to achieving profitability and securing a leadership role in the competitive medical imaging market. Clarius has cemented its position as an AI leader by deploying numerous AI technologies, including multiple FDA-cleared AI models. These models are integrated directly into the Clarius ultrasound App and are designed to simplify exams and provide clinical support. Key FDA-cleared AI models include Clarius Prostate AI, which automatically identifies and measures the prostate, and Clarius Median Nerve AI, which assists in locating and measuring the median nerve for Carpal Tunnel Syndrome assessments. Clarius’s continuous development of user-friendly and intelligent handheld solutions is securing the long-term viability and expansion of medical imaging accessibility.
Exo Imaging
Exo Imaging (Exo Inc.) is a key innovator in the Ultrasound AI market, known for pioneering the application of artificial intelligence in its handheld ultrasound platform, the Exo Iris. The company’s core technological contribution is SweepAI™, an FDA-cleared AI feature that continuously evaluates the quality of ultrasound images in real-time and provides immediate feedback to the user. This ensures that the clinician captures the best scan possible and indicates when enough diagnostic information has been collected, often taking only seconds. This technology significantly enhances image acquisition, reduces operator dependency, and minimizes the variability between different users. Exo AI also includes automated, FDA-cleared indicators for the assessment of various conditions, such as heart failure, cardiac hypertrophy, and pneumonia. Furthermore, SweepAI™ underpins Exo U, the company’s POCUS education approach, which provides AI-powered, real-time clinical training directly in the application, making ultrasound learning easier and more actionable for healthcare professionals globally.
DiA Imaging Analysis
DiA Imaging Analysis is an important player in the Ultrasound AI market, specializing in the development of artificial intelligence-based software solutions specifically for the automated analysis of medical ultrasound images. The company, which is a part of Philips, focuses on leveraging AI to streamline clinical workflows and standardize quantitative analysis, particularly within the cardiology segment. DiA’s technology is designed to reduce the high variability associated with manual view selection and visual analysis of cardiac ultrasound images. A notable example is its 2D Auto EF feature, integrated into Philips’ CV Ultrasound systems, which provides automated software for the preselection and analysis of optimal apical cardiac ultrasound views. This automation significantly enhances the precision, reproducibility, and ease of use for complex measurements, such as left ventricular ejection fraction and strain imaging, ultimately supporting clinicians in making faster, more informed diagnostic and treatment decisions.
Sonio
Sonio is a focused company in the Ultrasound AI market dedicated to Women’s Health, offering a secure, cloud-based ultrasound OB-GYN reporting software that incorporates clinical AI. The company’s mission is to expand access to high-quality prenatal care globally by bringing efficiency and quality control to clinical workflows. Sonio’s technology, including its FDA 510(k) cleared AI module Sonio Detect, leverages both image analysis and OCR neural networks. The solution provides AI-assisted exams, built-in Quality Control that verifies pre-defined criteria, and automated image management that sorts views for streamlined review. It also includes an automatic population of fields to generate reports quickly and efficiently. By integrating seamlessly with existing hospital systems (PACS, EHR, DICOM), Sonio empowers sonographers, OB-GYNs, and clinical executives with real-time feedback, ensuring image quality, report consistency, and billing accuracy, thereby elevating the standard of prenatal care.
Latest Market Research Report on Ultrasound AI Download PDF Brochure Now